[1]GARCIA-TSAO G, ABRALDES JG, BERIGOTTI A, et al.Portal hypertensive bleeding in cirrhosis:risk stratification, diagnosis, and management:2016 practice guidance by the American Association for the study of liver diseases[J].Hepatology, 65 (1) :310-335.
|
[2]SCHUPPAN D, AFDHAL NH.Liver cirrhosis[J].Lancet, 2008, 371 (9615) :838-851.
|
[3]D'AMICO G, PASTA L, MORABITO A, et al.Competing risks and prognostic stages of cirrhosis:a 25-year inception cohort study of 494 patients[J].Aliment Pharmacol Ther, 2014, 39 (10) :1180-1193.
|
[4]INFANTE-REVARD C, ESNAOLA S, VILLENEUVE JP.Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics[J].Hepatology, 1987, 7 (4) :660-664.
|
[5]HUO TI, LIN HC, LEE SD.Model for end-stage liver disease and organ allocation in liver transplantation:where are we and where should we go?[J].J Chin Med Assoc, 2006, 69 (5) :193-198.
|
[6] MALINCHOC M, KAMATH PS, GORDON FD, et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J].Hepatology, 2000, 31 (4) :864-871.
|
[7]FRREEMAN RB.Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era:evidence-based patient selection[J].Liver Transpl, 2004, 10 (10Suppl 2) :s2-s3.
|
[8]HUO TI, LEE SD, LIN HC.Selecting an optimal prognostic system for liver cirrhosis:the model for end-stage liver disease and beyond[J].Liver Int, 2008, 28 (5) :606-613.
|
[9]KIIM WR, BIGGINS SW, KREMERS WK, et al.Hyponatremia and mortality among patients on the liver-transplant waiting list[J].NEngl J Med, 2008, 359 (10) :1018-1026.
|
[10]CARDENAS A, GINES P.Predicting mortality in cirrhosis-serum sodium helps[J].N Engl J Med, 2008, 359 (10) :1060-1062.
|
[11]RUF AE, KREMERS WK, CHAVEZ LL, et al.Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone[J].Liver Transpl, 2005, 11 (3) :336-343.
|
[12]BIGGINS SW, KIM WR, TERRAULT NA, et al.Evidence-based incorporation of serum sodium concentration into MELD[J].Gastroenterology, 2006, 130 (6) :1652-1660.
|
[13]LV XH, LIU HB, WANG Y, et al.Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis[J].J Gastroenterol Hepatol, 2009, 24 (9) :1547-1553.
|
[14]D'AMICO, G, GATCIA-TSAO G, PAGLIARO L.Natural history and prognostic indicators of survival in cirrhosis:a systematic review of 118 studies[J].J Hepatol, 2006, 44 (1) :217-231.
|
[15]LUCA A, ANGERMAYR B, BERTOLINI G, et al.An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis[J].Liver Transpl, 2007, 13 (8) :1174-1180.
|
[16]CHENG XP, ZHAO J, CHEN Y, et al.Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis[J].Eur J Gastroenterol Hepatol, 2016, 28 (4) :444-448.
|
[17]BISELLI M, GITTO S, GRAMENZI A, et al.Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant:which is the winner?[J].Liver Transpl, 2010, 16 (8) :964-973.
|
[18]JIANG M, LIU F, XIONG WJ, et al.Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis[J].World J Gastroenterol, 2008, 14 (42) :6546-6550.
|
[19]HUO TI, Lin HC, HUO SC, et al.Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis[J].Liver Transpl, 2008, 14 (42) :837-844.
|
[20]FAN XL, YANG LI.Method to assess the accuracy of scores in mortality prediction:more than receiver operating characteristic curve[J].Eur J Gastroenterol Hepatol, 2016, 28 (7) :850.
|
[21]HUO TI, WANG YW, YANG YY, et al.Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis[J].Liver Int, 2007, 27 (4) :498-506.
|
[22]HUO TI, WU JC, LIN HC, et al.Evaluation of the increase in model for end-stage liver disease (Delta MELD) score over time as a prognostic predictor in patients with advanced cirrhosis:risk factor analysis and comparison with initial MELD and Child-TurcottePugh score[J].J Hepatol, 2005, 42 (6) :826-832.
|
[23]WIESNER R, EDWARDS E, FREEMAN R, et al.Model for end-stage liver disease (MELD) and allocation of donor livers[J].Gastroenterology, 2003, 124 (1) :91-96.
|
[24]RAHIMI-DEHKORDI N, NOURIJELYANI K, NASIRI-TOUSIM, et al.Model for End stage Liver Disease (MELD) and ChildTurcotte-Pugh (CTP) scores:ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions[J].Arch Iran Med, 2014, 17 (2) :118-121.
|
[25]GOTTHARDT D, WEISS KH, BAUMGARTNER M, et al.Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation[J].BMC Gastroenterol, 2009, 9:72.
|
[26]LEMESHOW S, HOSMER DW Jr.A review of goodness of fit statistics for use in the development of logistic regression models[J].Am J Epidemiol, 1982, 115 (1) :92-106.
|
[27]JOHNSON KB, CAMPBELL EJ, CHI H, et al.Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort[J].Dig Dis Sci, 2014, 59 (1) :174-182.
|
[28]LEE YH, HSU CY, HUO TI.Assessing liver dysfunction in cirrhosis:role of the model for end-stage liver disease and its derived systems[J].J Chin Med Assoc, 2013, 76 (8) :419-424.
|
[29]CHOLONGITAS E, MARELLI L, KERRY A, et al.Different methods of creatinine measurement significantly affect MELD scores[J].Liver Transpl, 2007, 13 (4) :523-529.
|
[30]TROTTER JF, OLSON J, LEFKOWITZ J, et al.Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory[J].Am JTransplant, 2007, 7 (6) :1624-1628.
|
[31]CHOLONGTITAS E, MARELLI L, KERRY A, et al.Female liver transplant recipients with the same GFR as male recipients have lower MELD scores-a systematic bias[J].Am J Transplant, 2007, 7 (3) :685-692.
|